You can watch SVA and buy or sell other stocks, options, ETFs, and crypto commission-free!
Sinovac Biotech, Ltd. Ordinary Shares, also called Sinovac Biotech, is a holding company, which engages in the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. Read More Its product portfolio includes vaccines against enterovirus71, or EV71, hepatitis A and B, seasonal influenza, H5N1 pandemic influenza, H1N1 influenza, and mumps. The company was founded in 1993 and is headquartered in Beijing, China.
52 Week High
52 Week Low
Yahoo FinanceApr 16
Sinovac Announces Positive Results From Phase III Trial Of a Sabin Strain-Based Inactivated Polio Vaccine (sIPV) Published in the Journal of Infectious Disease
BEIJING--(BUSINESS WIRE)-- The Sinovac-developed sIPV demonstrates both long-term affordability and accessibility and has the potential to contribute significantly to polio eradication in developing countries and the progress towards a polio-free world. Sinovac Biotech Ltd. (SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that the positive results from the Company’s Phase III clinical study of a Sabin strain-based inactivated polio vaccine (sIP...
Expected May 10, Pre-Market